These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 8892930

  • 1. Inhibition of human immunodeficiency virus type 1 and type 2 Tat function by transdominant Tat protein localized to both the nucleus and cytoplasm.
    Orsini MJ, Debouck CM.
    J Virol; 1996 Nov; 70(11):8055-63. PubMed ID: 8892930
    [Abstract] [Full Text] [Related]

  • 2. A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat.
    Pearson L, Garcia J, Wu F, Modesti N, Nelson J, Gaynor R.
    Proc Natl Acad Sci U S A; 1990 Jul; 87(13):5079-83. PubMed ID: 2195547
    [Abstract] [Full Text] [Related]

  • 3. Construction and characterization of a potent HIV-2 Tat transdominant mutant protein.
    Echetebu CO, Rhim H, Herrmann CH, Rice AP.
    J Acquir Immune Defic Syndr (1988); 1994 Jul; 7(7):655-64. PubMed ID: 8207644
    [Abstract] [Full Text] [Related]

  • 4. Trans-dominant Tat mutants with alterations in the basic domain inhibit HIV-1 gene expression.
    Modesti N, Garcia J, Debouck C, Peterlin M, Gaynor R.
    New Biol; 1991 Aug; 3(8):759-68. PubMed ID: 1931822
    [Abstract] [Full Text] [Related]

  • 5. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication.
    Beauparlant P, Kwon H, Clarke M, Lin R, Sonenberg N, Wainberg M, Hiscott J.
    J Virol; 1996 Sep; 70(9):5777-85. PubMed ID: 8709193
    [Abstract] [Full Text] [Related]

  • 6. Mutational analysis of the amino and carboxy termini of the HIV-2 Tat protein.
    Echetebu CO, Rice AP.
    J Acquir Immune Defic Syndr (1988); 1993 Jun; 6(6):550-7. PubMed ID: 8496787
    [Abstract] [Full Text] [Related]

  • 7. Human immunodeficiency virus type 2 (HIV-2) trans-activator (Tat): functional domains and the search for trans-dominant negative mutants.
    Arya SK.
    AIDS Res Hum Retroviruses; 1993 Sep; 9(9):839-48. PubMed ID: 8257633
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Inhibition of human immunodeficiency virus type 1 Tat activity by coexpression of heterologous trans activators.
    Carroll R, Peterlin BM, Derse D.
    J Virol; 1992 Apr; 66(4):2000-7. PubMed ID: 1312617
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Second exon of Tat of HIV-2 is required for optimal trans-activation of HIV-1 and HIV-2 LTRs.
    Tong-Starksen SE, Baur A, Lu XB, Peck E, Peterlin BM.
    Virology; 1993 Aug; 195(2):826-30. PubMed ID: 8337847
    [Abstract] [Full Text] [Related]

  • 14. Transcriptional activation in vitro by the human immunodeficiency virus type 1 Tat protein: evidence for specific interaction with a coactivator(s).
    Song CZ, Loewenstein PM, Green M.
    Proc Natl Acad Sci U S A; 1994 Sep 27; 91(20):9357-61. PubMed ID: 7937769
    [Abstract] [Full Text] [Related]

  • 15. Conservative mutations in the putative metal-binding region of human immunodeficiency virus tat disrupt virus replication.
    Sadaie MR, Mukhopadhyaya R, Benaissa ZN, Pavlakis GN, Wong-Staal F.
    AIDS Res Hum Retroviruses; 1990 Nov 27; 6(11):1257-63. PubMed ID: 2078407
    [Abstract] [Full Text] [Related]

  • 16. The human immunodeficiency virus Tat proteins specifically associate with TAK in vivo and require the carboxyl-terminal domain of RNA polymerase II for function.
    Yang X, Herrmann CH, Rice AP.
    J Virol; 1996 Jul 27; 70(7):4576-84. PubMed ID: 8676484
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Function of exon 2 in optimal trans-activation by Tat of HIV type 2.
    Pagtakhan AS, Tong-Starksen SE.
    AIDS Res Hum Retroviruses; 1995 Nov 27; 11(11):1367-72. PubMed ID: 8573394
    [Abstract] [Full Text] [Related]

  • 19. Sequential steps in Tat trans-activation of HIV-1 mediated through cellular DNA, RNA, and protein binding factors.
    Gatignol A, Duarte M, Daviet L, Chang YN, Jeang KT.
    Gene Expr; 1996 Nov 27; 5(4-5):217-28. PubMed ID: 8723388
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.